Delivery Order SPE2DB25D3002-SPE2DB25FLQAZ
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$28K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of 4,564,145,812 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine, with a ceiling value of $4,158.25 and a performance period through April 3, 2024. This delivery order is part of a larger indefinite delivery contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,058,855 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The award, valued at $5,904.85, is a firm fixed-price contract with a completion date of January 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and is registered in the...
This is a $11,486.75 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 4,564,804,496 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
This is a delivery order valued at $3,079.35 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,563,519,182 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a total ceiling value of $2,564.45. The contract is a firm fixed-price delivery order with a period of performance through February 2, 2024. This award is not designated as a...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order, valued at $9,363.10, is for 4,566,358,880 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,979,969 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The $6,268.05 delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp as the sole prime contractor. This IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,183,176 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has a ceiling value of $37,452.40 and a period of performance through April 8, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides 4,566,403,909 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine, with a ceiling value of $9,363.10. The contract has a period of performance through November 13, 2024 and is a Firm Fixed Price, Delivery Order contract. This award is not associated with a set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The order is for 4,565,393,908 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine and has a firm fixed price of $2,922.98. The award has an ultimate completion date of August 9, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this contract to supply critical medical commodities...